Trailing Twelve Months Revenue Growth: Citius Pharmaceuticals (CTXR)

Public company logo of Citius Pharmaceuticals Inc. (CTXR)

The YoY sales volume growth trajectory over the rolling period confirms Citius Pharmaceuticals (CTXR) business dependence on the final stages of drug trials. The 0.00 mark serves as a current indicator influenced by FDA delays and capital shortages. Meanwhile, patent protection for infection treatment methods cushions the decline, creating barriers for competitors in the hospital sector.

Citius Pharmaceuticals, Inc. (CTXR): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/17/2026

Citius Pharmaceuticals, Inc. - analytical breakdowns and key metrics (CTXR)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:citiuspharma.com
Brand item of citiuspharma.com

Value investing involves searching for early signals of a fundamental business turnaround. This indicator measures revenue dynamics over a rolling year, allowing for the real-time tracking of income recovery rates. For Citius Pharmaceuticals (CTXR), such a metric is critical during the market launch of Mino-Lok and hospital sector drugs. Growth confirms the commercial success of new products. Analyze the last twelve months (LTM) change in commercial revenue to assess the sustainability of the expansion.

Who Citius Pharmaceuticals competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) CRDF (cardiffoncology.com)|BYSI: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth BioAtla Corp (BCAB)|Sales Growth YoY (Last Twelve Months) Lixte Biotechnology Holdings, Inc.|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)